Intravenous ketamine for treatment of super-refractory convulsive status epilepticus with septic shock: A report of two cases

Indian Journal of Critical Care Medicine

Volumn 19, Issue 5, 2015, Pages 283-285

  Shrestha, Gentle Sunder ^a   Joshi, Pankaj ^a   Chhetri, Santosh ^a   Karn, Ragesh ^a   Acharya, Subhash Prasad ^a  

^a TRIBHUVAN UNIVERSITY TEACHING HOSPITAL   (Nepal)

Author keywords

Ketamine; septic shock; super refractory status epilepticus

Indexed keywords

CLOBAZAM; CREATININE; ETIRACETAM; IMMUNOGLOBULIN G ANTIBODY; KETAMINE; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORADRENALIN; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ACINETOBACTER; ADULT; ARTICLE; BRAIN DAMAGE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FATTY ACID DESATURATION; FEMALE; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MAINTENANCE THERAPY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE; SEPTIC SHOCK; SUPER REFRACTORY CONVULSIVE STATUS EPILEPTICUS; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; YOUNG ADULT;

EID: 84929245118     PISSN: 09725229     EISSN: 1998359X     Source Type: Journal    
DOI: 10.4103/0972-5229.156484     Document Type: Article

References (11)

1. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3-23.
2. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: A critical review of available therapies and a clinical treatment protocol. Brain 2011;134:2802-18.
3. Novy J, Rossetti AO. Oral pregabalin as an add-on treatment for status epilepticus. Epilepsia 2010;51:2207-10.
4. Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012;135:2314-28.
5. Hijazi Y, Bodonian C, Bolon M, Salord F, Boulieu R. Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury. Br J Anaesth 2003;90:155-60.
6. Morris C, Perris A, Klein J, Mahoney P. Anaesthesia in haemodynamically compromised emergency patients: Does ketamine represent the best choice of induction agent? Anaesthesia 2009;64:532-9.
7. Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study. Epilepsia 2013;54:1498-503.
8. Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res 2013;105:183-8.
9. Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H. A "malignant" variant of status epilepticus. Arch Neurol 2005;62:1428-31.
10. Krishnamurthy KB, Drislane FW. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996;37:863-7.
11. Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 2005;25:7724-33.